.gif)
SPINE
Celecoxib versus acetaminophen for pain & MRI scores in chronic non-specific LBP
Arthritis Care Res (Hoboken). 2016 Jun;68(6):845-5250 patients with non-specific low back pain (LBP) were randomized to receive either 200mg celecoxib twice a day or 500mg acetaminophen twice a day. The purpose of this study was to compare the clinical outcomes and magnetic resonance imaging (MRI) scores of the two treatments. Findings indicated a greater reduction of total back pain, Oswestry Disability Index scores, Bath Ankylosing Spondylitis Disease Activity Index scores, nocturnal back pain, and patient global assessment in the celecoxib group compared to the acetaminophen group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
